To page body
university of tampere: faculty of medicine and life sciences: research:
Faculty of Medicine and Life SciencesUniversity of TampereFaculty of Medicine and Life Sciences

Radiotherapy and Oncology

Professor:
Pirkko-Liisa Kellokumpu-Lehtinen
tel. +358 (0)50 595 1103 or +358 (0)3 3116 3227
pirkko-liisa.kellokumpu-lehtinen@uta.fi

Radiotherapy and Oncology Research:

The main research subjects are the most common forms of cancer; breast and prostate cancer and their new treatment interventions (anti-cancer drugs, radiation therapy, and psychosocial factors). Clinical drug trials in the area include adjuvant therapy and the treatment of invasive cancer using new targeted cancer drugs, cytostatics, and hormones, as well as radioactive drugs. This research group includes Docent Minna Tanner, Anna-Liisa Kautio MD, Maarit Bärlund MD, Niina Paunu MD, Specialist Petteri Hervonen and Registrar Leena Tianen. In addition to this, the effectiveness of radiation therapy as well as new techniques and fractionation models for the treatment of both breast cancer and prostate cancer are being developed in prospective clinical trials (Specialist Tanja Skyttä, Specialist Petri Reinikainen, Specialist Tapio Tulijoki, Tuija Wigren MD, and radiation therapy physicists). New cancer imaging methods and image processing algorithms are being developed and tested in cooperation with researchers from Tampere University of Technology (Specialist Hannu Pertovaara, and Xingchen Wu MD, PhD).

Quality of life and cost-effectiveness are also being studied, especially in connection with targeted treatments of kidney cancer and adjuvant therapy research into prostate and breast cancer, with topics including the importance of exercise in preventing the recurrence of breast cancer, improving quality of life, and promoting skeletal and cardiovascular health (BREX study).

Clinical trials are carried out in cooperation with several Finnish and international cancer groups, such as the Finnish Breast Cancer Group (FBCG), the Breast International Group (BIG), the Scandinavian Prostate Cancer Group (SPCG), the Ireland Cooperative Clinical  Research Group, and the uro-onco and melanoma groups of the Finnish Oncology Society, as well as general researchers from MED and BioMedTech (the Prostate Cancer Research Centre; molecular biological predictive and prognostic factors).  With the School of Health Sciences and the National Institute for Health and Welfare (THL), cooperation is focused on the psychosocial effects of cancer and the development of support interventions.

Cooperation is also carried out with the international pharmaceutical industry in several prospective clinical drug trials that focus primarily on the aforementioned forms of cancer.


Palliative Medicine

Professor:
Juho Lehto
tel. +358 (0)50 318 6351
juho.lehto@uta.fi

 
Maintained by: med.info@uta.fi
Last update: 27.3.2014 10.11 Muokkaa

University of Tampere
+358 3 355 111
registry@uta.fi


FINEEC Audited HR Excellence in Research

THE UNIVERSITY
Research
Admissions
Studies
News
Cooperation and Services
About Us

CURRENT ISSUES
Research & Study
Tampere3
Vacancies

SERVICES
Administration
Career Services
Finnish Social Science Data Archive
Centre for International Education
IT services
Language Centre
Language Services
Library
Registrar's Office
Registry
Sports Activities
» more

STUDIES
Teaching schedules
Curricula guides
Student's Desktop

ONLINE SERVICES
Andor search
Renew your loans
UTA intranet
Office 365 webmail
Uta webmail
Moodle
NettiOpsu
NettiKatti
TamPub
Electronic exam service
Examination results